Trade PODD anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Insulet Corporation (PODD) is trading at US$145.13, up 1.20% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$10.28B. Over the past 52 weeks, PODD has traded between US$126.40 and US$354.88. On Syfe you can trade PODD with $0 commission and add it to your watchlist.
| Previous close | US$143.41 |
|---|---|
| Market cap | US$10.28B |
| P/E ratio | 19.87 |
| 52-week range | US$126.40 – US$354.88 |
| Volume | 1.04M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Insulet Corporation
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
Year: 2007
Insulet Corporation (PODD) stock is trading at US$145.13, +1.20% from the previous close of US$143.41.
The market cap for Insulet Corporation (PODD) stock is approximately US$10.28B.
The price-to-earnings ratio for Insulet Corporation (PODD) is 19.87, based on the latest reported earnings.
The 52-week high for Insulet Corporation (PODD) stock is US$354.88.
The 52-week low for Insulet Corporation (PODD) stock is US$126.40.
Insulet Corporation (PODD) does not currently pay a dividend.
Stay on top of PODD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
